ABSTRACT-
In vascular smooth muscles, neurotransmitters or autacoids produce contraction through activation of Cat+-influx and release of Ca 2+ from intracellular store sites. These agonists appear to activate Ca2+-influxes in both voltage-dependent and voltage-independent manners. The release of Ca 2+ is thought to be linked to the action of inositol 1,4,5-trisphosphate. The phosphorylation of myosin light chain may be the mechanism for the Ca2+-induced contraction in smooth muscles. Some agonists only transiently increase cellular Ca 2+ and the phosphorylation of myosin, but they produce a sustained contraction in various vascular tissues. Hence, additional high Ca2+-sensitive mechanisms are no doubt involved in the contraction of vascular smooth muscle. In the present article, attention will be directed to the mechanisms and agonist-induced contraction in arterial smooth muscle.
Introduction
Calcium ion has an essential role in the contraction of vascular smooth muscle. Cellular Ca 2+ is increased by an activation of influx and the release of Ca 2+ from store sites in the smooth muscle cell. It has been suggested that autacoids or neurotransmitters activate Ca2+-influxes, in both voltage-dependent and voltage-independent manners in vascular smooth muscle, although a controversy remains as to whether voltage independence is a valid notion (1, 2). Inositol 1,4,5-trisphosphate (IP3) appears to be a second messenger involved in the agonist-induced Ca2+ release in vascular smooth muscle cells (3, 4).
Phosphorylation of myosin seems to be the mechanism responsible for the contraction activated by cellular Ca 2+ increases (5). However, there is evidence that the regulatory mechanism for tension does not depend solely on the phosophorylation of myosin (6). Phosphorylation of the myosin light chain (MLC) is apparently not closely associated with the steady-state level of tension in vascular smooth muscle (7). Furthermore, autacoids or neurotransmitters transiently increase cellular Ca 2+ but maintain the contraction (8). Therefore, the theory of myosin phosphorylation probably cannot entirely explain muscle contraction.
Second messengers, such as cyclic adenosine 3',5'-monophosphate (cAMP), cyclic guanosine 3',5'-monophosphate (cGMP) and 1,2-diacylglycerol (DG), regulate cellular Ca 2+ and/or change the Ca2+-sensitivity of contractile proteins in smooth muscles (9, 10). This article gives a brief overview of recent elucidations of pharmacomechanical coupling in arterial vascular smooth muscles.
Pharmacomechanical coupling
In 1964, Su et al. (11) found that NE appears to produce a contraction without any change in the membrane potential in the rabbit main pulmonary artery. Somlyo and Somlyo (1968) also noted the generation of contraction with no change in the membrane potential in vascular smooth muscle and named this "pharmacomechanical coupling" (12). Much evidence has been reported supporting the presence of this mechanism in arterial smooth muscles of various species (13). In smooth muscle cells of the rabbit mesenteric artery, nerepinephrine (NE) at a concentration of less than 30 nM produces contraction with no change in the membrane potential; but at concentrations over 1 ,uM, NE evokes contraction with membrane depolarization (14). In smooth muscle cells of the porcine coronary artery, acetylcholine (ACh) produces contraction with no change in the membrane potential and resistance (15) . Thus, pharmacomechanical coupling mechanisms seem to be important for the agonist-induced contraction in arterial smooth muscles.
How can an agonist increase intracellular concentrations of Ca 2+ ([Ca 2+1i) in vascular smooth muscles without membrane depolarization ? In smooth muscle strips of the rabbit mesenteric artery, NE produces a phasic and following tonic increases in the [Ca 2+]; and tension. The tonic responses with oscillations ceased in Ca2+-free solution but the phasic one persisted. In smooth muscle strips of the porcine coronary artery, ACh produces a mono tonic and maintained contraction in solution containing 2.6 mM-Ca2+; but in Ca2+-free solution, this agonist only transiently increases the tension. Thus, in smooth muscles of the rabbit mesenteric and porcine coronary arteries, NE or ACh produces the initial contraction as a result of a release of Ca-+ from intracellular store sites, and the nature of the tonic contraction probably results from an interplay between increases in the influx and release of Ca 2+ from the store sites (13-18). Supportive evidence for this has been obtained with other arterial smooth muscles from various species (13).
In the smooth muscle of the rabbit mesenteric artery, NE activates the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP-,) and synthesizes IP3, and this product releases Ca2+ from the store sites (4). In smooth muscle cells of the porcine coronary artery, ACh synthesizes IP3 which releases Ca 2+ from the stores (19) . Supportive evidence has been obtained using other arterial smooth muscles from various species (20) . It has been suggested that IP3 is a second messenger for the agonist-induced Cat+-release in vascular smooth muscle cells, the same as in other nonmuscle cells (3).
Based on the results obtained from measurements of tension and cellular Ca 2+, it has been suggested that the agonist activates Ca 2+-influxes in both voltage-dependent and voltage-independent manners in vascular smooth muscle cells (21) . This hypothesis is mainly supported by the following: 1) NE or ACh can produce tonic contraction without altering membrane depolarization, as described above. 2) Organic Ca 2+-antagonists, such as nifedipine, nimodipine, nisoldipine and so on, completely block the tonic increase of [Ca 2-+]; and tension induced by high-K+, but only partly inhibit the tonic responses induced by an agonist (21 -23) . Benham and Tsien (1988) found that NE activates y-adrenergic receptors (Hirst and Nield, 1980 ) (24) and increased the dihydropyridine-sensitive L-type Ca 2+ current in single smooth muscle cells from the rabbit ear artery (25) . Nelson et al. (1988) found that in the rabbit mesenteric artery, NE increases the open probability of the Ca'+-channel (Ltype), possibly via involvement of an intracellular second messenger (2). Since the contraction induced by NE under the membrane depolarized conditon is inhibited by nisoldipine, these results suggest that NE produces a yet to be identified second messenger and increase the tension through only activation of the voltage-dependent Ca 2+-channel. Ba2+ has been used instead of Ca 2+ to study NE-actions on the current in whole cell or single Ca 2 +-channel recording in smooth muscle cells. In the presence of BaCl2, the contraction produced by NE is inhibited by nisoldipine, while this drug cannot block the NEinduced contraction in Ca2+-containing solution (26) . Benham and Tsien (1987) found that ATP activates the Ca 22+ and Na+ sensitive inward current which is resistant to Cd2+ or nifedipine and opens even at very negative potentials in single smooth muscle cells of the rabbit ear artery (1). Thus, it remains unknown whether the receptor-operated Ca 2+ channel activated by NE is present in vascular smooth muscle cells.
Myosin phosphorylation and contraction in living smooth muscle
Putative mechanisms underlying the Ca 2+ regulated force development in smooth muscles have been described (6). Phosphorylation of MLC by Ca 2 +-calmodulin myosin light chain kinase (MLCK) has been thought to be a most plausible mechanism involved in Ca2+-regulated force generation. The scheme of this mechanism is as follows: when Ca 2+ increases in vascular smooth muscle cell, Ca binds to calmodulin and phosphorylates MLC through activation of MLCK and then generates contraction. This hypothesis was first identified in the actin activated myosin ATPase activity of isolated contractile proteins of smooth muscles (5). However, it is still controversial whether the myosin phosphorylation theory is the only mechansism that can adequately explain smooth muscle contraction in vivo (6, 9). Secondly, using membrane permeabilized smooth muscle (skinned smooth muscle) strips, the relation between tension and level of MLC-phosphorylation is more directly compared in clamped cellular Ca 2+ concentration (using high concentrations of Ca 2+ sensitive chelator). Since Ca2 concentration is supposed to be constant under a steady state condition in skinned muscle strips, the data obtained could give more direct evidence about the Ca 2+ dependent relation between tension and MLC-phosphorylation under a modified intracellular environment. So far, several methods have been developed to make skinned smooth muscles using detergents such as Triton X-100 or saponin. Sparrow et al. (1981) found that in Triton X-100 treated strips, exogenously applied calmodulin increased both the sensitivity of the contractile proteins to Ca 2+ and the maximal Ca 2+ induced tension (27) . In the same detergent treated strips, Walsh et al. (1983) reported that Ca `+-calmodulin independent form of MLCK (made by trypsin) can produce the contraction in the absence of Ca 2+ (28) . Furthermore, Ca 2+ independent contraction can also be produced by application of Mg-ATP containing Ca22+-free solution following the addition of Ca 22+ and ATP7S solution (due to irreversible MLC phosphorylation) (29) . Saponin treated skinned muscles seem to retain a more physiological condition because the maximal Ca 2+ induced contraction can be produced without exogenously applied calmodulin (14-16). In these muscles, the Ca 2+-independent contractions described above are also observed (30) . Recently, using a-toxin or ,8-escin, new methods to make skinned smooth muscles have been reported and these muscles retain more physiological conditions than the other types of preparations (31, 32) . These data on skinned muscles or skinned single cells (33) seem to give more direct support for the myosin phosphorylation theory on the contraction in smooth muscles. However, since skinned muscle has no intact plasma membrane, leakage of some important proteins or substances on contractile systems would be possible. Furthermore, the effects of artificial conditions in skinned solutions such as pH or Mgt+, Na+ or Mg-ATP concentration and so on, should be justified based on the physiological conditions. Recently, we tried to clarify the role of MLC phosphorylation in contraction of smooth muscle more directly, using a method which has both advantages in skinned and living smooth muscle cells. A newly developed digital imaging technique and the Ca 2+-sensitive dye Fura 2 allowed us to directly measure the cellular Ca2+ concentration in a single smooth muscle eel (34) . In order to clarify the role of the Ca 2+-calmodulin-MLCK pathway on contraction in smooth muscle cells, we micro-injected trypsin-treated MLCK or its inhibitory peptides in a single smooth muscle cell from the stomach muscularis of the toad Bufo Marius, where intracellular Ca 2+ concentration was measured by Fura 2 fluorescence intensities using a dual wavelength, high time resolution fluorimeter (35) . The cell length was also measured at the same time. I will briefly review these results below.
To test if MLCK has a crucial role in the contraction of smooth muscles, trypsin treated MLCK (from turky gizzard) or Ca 2+ was micro-injected into single smooth muscle cells. This proteolysed MLCK (IMLCK) is an active form, different from the Ca 2+-calmodulin activated form, and its activity is almost the same as that of the original MLCK activated by the maximal Ca 22+ and calmodulin (assumed to be the main catalytic domain of MLCK) (36) . Ca 2+ injection produced a transient rise in Ca 2+ and cell shortening which reversed after Ca 2+ returned to the resting condition. In contrast, following injection of IMLCK, the cell maximally shortened without significantly increase of [Ca 2+]i, where the maximum rate and extent of the cell shortening were almost the same as that seen following microinjection of Ca2+ or depolarization by high-K+. The estimated activity of the kinase that resulted from injection of the purified IMLCK (0.16 nmol phosphate min' per ml cell water) was comparable with the endogenous MLCK activity expected when these cells are maximally activated (0.32 nmol phosphate min-' per ml cell water). These results indicate that activation of MLCK itself is sufficient to produce a contraction indistinguishable from that seen following stimuli acting to increase Ca 2+ concentration in the normal way. At the next step, actions of modulators of MLCK activity were investigated. Figure 1 shows the schematic diagram of MLCK and the amino acid compositions of its inhibitory peptides. SMl is a pseudo-substrate peptide that corresponds to amino acid residues 480 -501 of the smooth muscle MLCK and has weaker calmodulin antagonist properties (37) . RS20 is a strong calmodulin antagonist and has weak substrate antagonist activity that corresponds to residues 493-512 (38) . Thus, these two synthetic peptides are supposed to act principally at different sites in the Ca 2+-calmodulin-MLCK pathway. Possible sites of action of the two peptide are shown in Fig. 2 . As expected from biochemical results, SM1 (10,uM) completely, but not RS20 (10,uM), inhibited the cell shortening induced by injection of IMLCK when co-injected in a single smooth muscle cell (34) .
To investigate the role of the Ca 2+-calmodulin-MLCK pathway on smooth muscle contraction under physiological conditions, the effects of the two synthetic peptides were investigated on the changes of [Ca 2+]; and cell length induced by briefly applied high-K+-depolarization. Transient depolarization of the cell with high-K+ caused a transient increase in Ca 2+ and shortening of the cell. Both SM1 and RS20 inhibited the cell shortening but increased the cellular Ca2+ changes induced by high-K+. The inhibitory actions of either peptide on cell shortening were observed at any Ca 2+ concentration (34) . These results indicate that the pathway by which Ca 2+ leads to activation requires both calmodulin and MLCK activation. As contraction induced by Ca 2+ or IMLCK injection can be both inhibited by SM1, activation of MLCK could be an obligatory step in the pathway leading from Ca 2+ increases to cell shortening. We con- The possible mechanisms involved in the induction by cAMP have been thought to be as follows: cAMP increases the rate of Ca 2+ uptake in the store site and then causes a decrease of [Ca 2+]i or cAMP decreases the affinity of MLCK to the Ca t+-calmodulin complex through the phosphorylation of the kinase and then causes vasodilation. The former mechanism has been well-studied in cardiac muscle (39) and also recently has been found in purified smooth muscle membrane proteins (40) and in saponin-treated skinned smooth muscle (41) . The latter actions of cAMP were proposed by Sellers and Adelstein (42) . They found that in the absence of Ca-+-calmodulin, cAMP-dependent protein kinase phosphorylates MLCK at two sites (A and B sites) and in the presence of Ca '`+-calmodulin, it phosphorylates the kinase only at 1 site (B site). Phosphorylation of site A decreases the affinity of MLCK for Ca t+-calmodulin. However, it still has been controversial whether cAMP increasing agents produce vasodilation through MLCK-phosphorylation by cAMP dependent protein kinase (9). cGMP: Nitrites, organic nitrate, nitroso compounds, and nitrogen oxide lead to the formation of nitric oxide (NO) which activates soluble guanyl cyclase and increases cGMP in smooth muscle (43) . Recent studies have indicated that endothelium derived relaxing factor is actually NO, which relaxes the vascular tissue with an increase of cellular cGMP. The mechanisms of vasodilation induced by cGMP has not been fully understood. In smooth muscle strips of the rabbit mesenteric artery, we suggested that nitroglycerin (NG) or 8-bromocGMP inhibits the contraction induced by NAd, probably due to the activation of the Ca t+-extrusion mechanism on the plasma membrane (16) . Using the Ca t+-sensitive dye quin 2, Kobayashi et al. (1985) obtained more direct evidence for this in cultured smooth muscle (44). Recently, it was reported that in the microsomal fraction of smooth muscle plasma membrane, cGMP-dependent protein kinase activates Ca t+-ATPase acitivity (45) . Thus, increases of Ca 2+-pump activity on the plasma membrane may partly explain the mechanism of vasodilation induced by cGMP increasing agents.
cGMP dependent protein kinase phosphorylates MLCK at site B in the absence of Ca `+-calmodulin but not in the presence of Ca t+-calmodulin (46) . However, this phosphorylation is not known to have inactivation effects on MLCK. Thus, cGMP dependent protein kinase seems to have no direct inhibitory actions on contractile machinery of smooth muscle. However, Yanagisawa et al. (1989) found that NG inhibits the contraction induced by high-K+ with a minor decrease of the [Ca 2+]i in dog coronary artery (47). This may suggest that cyclic GMP or NG itself has some effects on contractile proteins in smooth muscle. These remain to be clarified.
DG: DG is a co-product of IP3 produced through the hydrolysis of PIP,, and this activates protein kinase C and enhances Cat+-sensitivities of the contractile proteins in skinned smooth muscle strips (9, 48). Phorbol esters, activators of protein kinase C, increase contraction without increase of [Ca 2+]i in smooth muscles (49). In vascular smooth muscles, agonists transiently increase [Ca 2+]; and phosphorylation of MLC, but produces sustained contraction (6, 8). For this reason, it has been speculated that the myosin phosphorylation may be responsible for the initiation of contraction, while protein kinase C may be responsible for the maintained contraction in smooth muscle (10). However, protein kinase C phosphorylates both MLC and MLCK in vitro and these lead to inhibition of actomyosin ATPase activity (9). Furthermore, addition of protein kinase C phosphorylates MLC and inhibits the maximum Ca 2+-contraction in skinned vascular smooth muscle (50). Thus, these contradictory results make it difficult to assess the physiological role of protein kinase C. These might be due to the unknown phosphorylation sites of protein kinase C in smooth muscle. These should be clarified under physiological conditions.
